Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

The Albumin in Subarachnoid Hemorrhage (ALISAH) multicenter pilot clinical trial: safety and neurologic outcomes.

Suarez JI, Martin RH, Calvillo E, Dillon C, Bershad EM, Macdonald RL, Wong J, Harbaugh R; ALISAH Investigators.

Stroke. 2012 Mar;43(3):683-90. doi: 10.1161/STROKEAHA.111.633958. Epub 2012 Jan 19.

2.

The ALIAS Pilot Trial: a dose-escalation and safety study of albumin therapy for acute ischemic stroke--I: Physiological responses and safety results.

Ginsberg MD, Hill MD, Palesch YY, Ryckborst KJ, Tamariz D.

Stroke. 2006 Aug;37(8):2100-6. Epub 2006 Jun 29.

3.

The ALIAS Pilot Trial: a dose-escalation and safety study of albumin therapy for acute ischemic stroke--II: neurologic outcome and efficacy analysis.

Palesch YY, Hill MD, Ryckborst KJ, Tamariz D, Ginsberg MD.

Stroke. 2006 Aug;37(8):2107-14. Epub 2006 Jun 29.

4.

Treatment of subarachnoid hemorrhage with human albumin: ALISAH study. Rationale and design.

Suarez JI, Martin RH.

Neurocrit Care. 2010 Oct;13(2):263-77. doi: 10.1007/s12028-010-9392-8.

PMID:
20535587
5.

Randomized, Open-Label, Phase 1/2a Study to Determine the Maximum Tolerated Dose of Intraventricular Sustained Release Nimodipine for Subarachnoid Hemorrhage (NEWTON [Nimodipine Microparticles to Enhance Recovery While Reducing Toxicity After Subarachnoid Hemorrhage]).

Hänggi D, Etminan N, Aldrich F, Steiger HJ, Mayer SA, Diringer MN, Hoh BL, Mocco J, Faleck HJ, Macdonald RL; NEWTON Investigators.

Stroke. 2017 Jan;48(1):145-151. doi: 10.1161/STROKEAHA.116.014250. Epub 2016 Dec 8.

7.
8.

Effects of prostacyclin on cerebral blood flow and vasospasm after subarachnoid hemorrhage: randomized, pilot trial.

Rasmussen R, Wetterslev J, Stavngaard T, Juhler M, Skjøth-Rasmussen J, Grände PO, Olsen NV.

Stroke. 2015 Jan;46(1):37-41. doi: 10.1161/STROKEAHA.114.007470. Epub 2014 Nov 20.

9.

Human Albumin Improves Long-Term Behavioral Sequelae After Subarachnoid Hemorrhage Through Neurovascular Remodeling.

Xie Y, Liu W, Zhang X, Wang L, Xu L, Xiong Y, Yang L, Sang H, Ye R, Liu X.

Crit Care Med. 2015 Oct;43(10):e440-9. doi: 10.1097/CCM.0000000000001193.

PMID:
26181220
10.

Effects of a single dose of dantrolene in patients with cerebral vasospasm after subarachnoid hemorrhage: a prospective pilot study.

Muehlschlegel S, Rordorf G, Sims J.

Stroke. 2011 May;42(5):1301-6. doi: 10.1161/STROKEAHA.110.603159. Epub 2011 Mar 31.

11.

High-dose simvastatin for aneurysmal subarachnoid hemorrhage: multicenter randomized controlled double-blinded clinical trial.

Wong GK, Chan DY, Siu DY, Zee BC, Poon WS, Chan MT, Gin T, Leung M; HDS-SAH Investigators.

Stroke. 2015 Feb;46(2):382-8. doi: 10.1161/STROKEAHA.114.007006. Epub 2014 Dec 16.

12.

Neuroprotective effect of an antioxidant, ebselen, in patients with delayed neurological deficits after aneurysmal subarachnoid hemorrhage.

Saito I, Asano T, Sano K, Takakura K, Abe H, Yoshimoto T, Kikuchi H, Ohta T, Ishibashi S.

Neurosurgery. 1998 Feb;42(2):269-77; discussion 277-8.

PMID:
9482177
13.

Prognostic value of premorbid hypertension and neurological status in aneurysmal subarachnoid hemorrhage: pooled analyses of individual patient data in the SAHIT repository.

Jaja BN, Lingsma H, Schweizer TA, Thorpe KE, Steyerberg EW, Macdonald RL; SAHIT collaboration.

J Neurosurg. 2015 Mar;122(3):644-52. doi: 10.3171/2014.10.JNS132694. Epub 2015 Jan 2.

PMID:
25554825
14.
15.

High-dose simvastatin for aneurysmal subarachnoid hemorrhage: a multicenter, randomized, controlled, double-blind clinical trial protocol.

Wong GK, Liang M, Tan H, Lee MW, Po YC, Chan KY, Poon WS.

Neurosurgery. 2013 May;72(5):840-4. doi: 10.1227/NEU.0b013e31828ab413.

PMID:
23392270
17.

Lumbar drainage of cerebrospinal fluid after aneurysmal subarachnoid hemorrhage: a prospective, randomized, controlled trial (LUMAS).

Al-Tamimi YZ, Bhargava D, Feltbower RG, Hall G, Goddard AJ, Quinn AC, Ross SA.

Stroke. 2012 Mar;43(3):677-82. doi: 10.1161/STROKEAHA.111.625731. Epub 2012 Jan 26.

18.

Effect of human albumin on TCD vasospasm, DCI, and cerebral infarction in subarachnoid hemorrhage: the ALISAH study.

Suarez JI, Martin RH, Calvillo E, Bershad EM, Venkatasubba Rao CP.

Acta Neurochir Suppl. 2015;120:287-90. doi: 10.1007/978-3-319-04981-6_48.

PMID:
25366638
20.

Randomized, double-blind, placebo-controlled, pilot trial of high-dose methylprednisolone in aneurysmal subarachnoid hemorrhage.

Gomis P, Graftieaux JP, Sercombe R, Hettler D, Scherpereel B, Rousseaux P.

J Neurosurg. 2010 Mar;112(3):681-8. doi: 10.3171/2009.4.JNS081377.

PMID:
19522571

Supplemental Content

Support Center